Skip to main content
. Author manuscript; available in PMC: 2014 Feb 15.
Published in final edited form as: Cancer. 2012 Sep 18;119(4):915–923. doi: 10.1002/cncr.27785

Figure 6. UBE4B effects on growth of neuroblastoma cells and response to EGFR inhibitors.

Figure 6

A. SK-N-AS neuroblastoma tumor cells were treated with escalating concentrations of cetuximab. Cell growth was assessed at the indicated time points using the WST-1 based spectrophotometric assay. B. Parental SK-N-AS cells and SK-N-AS cells expressing either GFP (control), UBE4B, or UBE4BP1140A were grown in the presence of 4μM cetuximab (Erbitux) with growth assessed as above.